TAVO-605

N/A

Report date: 2025/06/30 16:21:50

Base Information

Drug NameTAVO-605
Drug Alias NameTAVO-605TAVO605
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CUB domain-containing protein 1
TargetsCUB domain-containing protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTavotek Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTavotek Biotherapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A